Clinical Trial

A Study Evaluating BAT3306 Compared With Keytruda® in NSCLC Cancer Participants

Recruiting Phase 1
View on ClinicalTrials.gov →
Summary
Comparing the PK similarity of BAT3306 and Keytruda; in NSCLC participants who were completely removed by surgery as an auxiliary treatment
Protocol Amendment History 1 change
notable Enrollment increased: 140 -> 160 participants 2026-07-19
Trial Details
NCT Number NCT07180862
Lead Sponsor Bio-Thera Solutions
Conditions Carcinoma, Non-Small-Cell Lung
Enrollment 160 participants
Start Date 2025-10-14
Primary Completion 2027-02-28 (estimated)
Study Completion 2027-11-30 (estimated)
Updated on ClinicalTrials.gov 2026-07-17